Home

Ra Capital Management reported a 19.9% stake in Tyra Biosciences TYRA · 14,130,492 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
19.9%
Last report
21.2% · filed 26/03/06
Shares held
14,130,492 sh
Class
Common Stock, $0.0001 par value per share
Event date
26/09/15
Filed
26/09/17

19.9% stake · −1.3pp from the last report

Stake
19.9%
Last report
21.2%
Since last report
−1.3pp

Tyra Biosciences trades, last 26 weeks

What else happened in Tyra Biosciences around then

Filed or reported within 30 days of the trade day · 08/16~10/15

Ra Capital Management's other 5% stake reports

  • Ra Capital Management

    5% stakeCorbus Pharmaceuticals Holdings

    9.9% stake

    Filed 09/30

  • Ra Capital Management

    5% stakeBetterLife Pharma

    9% stake

    Filed 09/22

  • Ra Capital Management

    5% stakeSionna Therapeutics

    14.3% stake

    Filed 09/21

  • Ra Capital Management

    5% stakeJatt III Acquisition

    5.1% stake

    Filed 09/03

  • Ra Capital Management

    5% stakeLatigo Biotherapeutics

    8.4% stake

    Filed 08/17